Latest Biosimilar Stories
According to the new report from BCC Research, the global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a
MANNHEIM, Germany, March 23, 2015 /PRNewswire-iReach/ -- The Biosimilars Group offers as a new and unique service to its clients - a one-day workshop for full biosimilar development project
Timely survey released as FDA approves first biosimilar WASHINGTON, March 23, 2015 /PRNewswire/ -- The Alliance for Safe
In a March 31 webinar, three veteran pharmacy observers will detail steps payers can take now to develop effective biosimilars management strategies. Washington,
LONDON, March 17, 2015 /PRNewswire/ -- Report DetailsBiosimilar therapeutic antibodies - see why originator companies should now fear those competitors, discovering their trends
CE Class Focuses on Fundamentals of Biosimilars EAST ELMHURST, N.Y., March 16, 2015 /PRNewswire/ -- With the U.S.
According to the new report from BCC Research, the global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014.
WASHINGTON, March 6, 2015 /PRNewswire-USNewswire/ -- The Alliance for Safe Biologic Medicines today commended the U.S.
LAKE FOREST, Ill., March 6, 2015 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), applauds Sandoz and the U.S.
- an ornament or knob in the shape of a flower
- In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.